PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954692
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954692
The global dental orthobiologics market size was valued at USD 1,000.19 million in 2025 and is projected to grow from USD 1,048.06 million in 2026 to USD 1,612.59 million by 2034, exhibiting a CAGR of 5.50% during the forecast period (2026-2034). North America dominated the market in 2025, accounting for a 48.73% share, driven by high dental implant volumes and strong product innovation.
Dental orthobiologics include natural and synthetic materials designed to promote bone, cartilage, and soft tissue regeneration in dental applications. These products comprise allografts, synthetic bone graft substitutes, demineralized bone matrix, cellular allografts, bone growth factors, and other biologics used in procedures such as dental implants, periodontal regeneration, and jawbone reconstruction.
Market Dynamics
The market is expanding due to the increasing prevalence of dental disorders such as edentulism, periodontal disease, and alveolar bone loss. These conditions frequently require bone grafting and regenerative procedures, thereby driving demand for orthobiologic materials. According to global health reports, oral diseases affect billions of people worldwide, with edentulism showing significant prevalence among aging populations.
The COVID-19 pandemic temporarily reduced market revenues in 2020 as dental clinics restricted services. However, recovery began in 2021 with the reopening of clinics and increased adoption of implant surgeries and bone grafting procedures. The growing use of tele-dentistry and digital treatment planning further supported procedural volumes.
Key Market Trends
A significant trend shaping the dental orthobiologics market is the rapid increase in dental implant procedures. Bone graft substitutes are widely used to enhance jawbone volume and ensure implant stability when natural bone is insufficient. Technological advancements in implantology have increased procedural complexity, further boosting the need for advanced regenerative materials.
Another emerging trend is the growing adoption of synthetic and 3D-printed bone graft substitutes. These products offer improved biocompatibility, predictable regeneration outcomes, and cost efficiency compared to traditional grafts. Innovations in biomaterials are enabling more customized solutions for complex dental surgeries.
Growth Drivers
The rising prevalence of dental bone disorders is a primary growth driver. Periodontal disease, tooth loss, and jawbone atrophy require regenerative procedures supported by orthobiologic materials. Increasing awareness among clinicians about advanced regenerative solutions is also accelerating adoption.
Additionally, the growing use of synthetic bone substitutes is fueling market growth. These materials reduce the risk of immune reactions and disease transmission while offering improved osteoconductive properties. Their affordability and ease of availability further enhance adoption across emerging markets.
Strategic acquisitions and collaborations among industry players are also strengthening product portfolios and expanding global distribution networks.
Restraining Factors
Despite growth potential, clinical limitations may restrict market expansion. Some orthobiologic products are associated with adverse tissue reactions, incomplete bone formation, and immunogenic risks. Complications related to bone morphogenetic proteins and xenografts, such as inflammation or graft displacement, may hinder adoption.
Furthermore, concerns regarding mechanical strength, resorption rates, and long surgical times can affect clinician preference and patient outcomes, posing challenges to market growth.
Market Segmentation Analysis
By Product Type
The bone growth factors segment dominated with a 41.31% share in 2026, driven by rising dental implant procedures that require enhanced bone regeneration. Synthetic bone graft substitutes are expected to grow at a higher CAGR due to their biocompatibility, lower production costs, and increasing export collaborations.
By Form
The paste segment held 45.35% of the market share in 2026, supported by strong R&D focus and widespread use of bone growth factors in paste form. The granules segment is projected to grow at a higher CAGR due to superior osteoblast attachment and increasing product launches.
By End-user
The solo practices segment accounted for 60.49% share in 2026, owing to a large number of independent dental clinics and high patient preference. DSO/group practices are anticipated to grow at a faster rate due to consolidation trends and rising procedural volumes.
North America generated USD 487.37 million in 2025, maintaining its leadership due to advanced healthcare infrastructure and frequent product launches.
Europe represents the second-largest market, supported by strong players such as Institut Straumann AG and Geistlich Pharma AG.
Asia Pacific is projected to grow at the highest CAGR, driven by rising dental disease prevalence, increasing healthcare spending, and growing penetration of advanced products in Japan, China, and India.
Latin America and the Middle East & Africa are expected to witness steady growth due to rising awareness and healthcare investments.
Key Industry Players
Leading companies include ZimVie Inc., Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, Medtronic, BioHorizons, NovaBone, and Geistlich Pharma AG. Strategic acquisitions, product launches, and geographic expansions are central to maintaining competitive advantage.
Conclusion
The global dental orthobiologics market is set for steady expansion, increasing from USD 1,000.19 million in 2025 to USD 1,612.59 million by 2034, at a CAGR of 5.50%. Growth is driven by rising dental implant procedures, increasing prevalence of bone disorders, and advancements in synthetic graft technologies. Although clinical limitations pose challenges, continuous innovation, strategic collaborations, and expanding dental care infrastructure are expected to sustain long-term market growth worldwide.
Segmentation By Product Type
By Form
By End-user
North America (By Product Type, Form, End-user, Country)